KLK3 and cancer: Nearly 40% of the patients undergoing RP present clinic-pathologic features associated with increased risk of clinical metastasis such as rising PSA (Prostate Specific Antigen, an indicator of risking cancer) , high Gleason score, seminal vesicle invasion or lymph node involvement2, 3, 4, 5.